US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Incyte

87.30

+1.131.31%

Post-market: 87.300.00000.00%18:53 EDT

Volume:1.14M

Turnover:98.91M

Market Cap:17.05B

PE:19.99

High:87.48

Open:85.65

Low:85.55

Close:86.17

52wk High:92.86

52wk Low:53.56

Shares:195.28M

Float Shares:163.04M

Volume Ratio:0.50

T/O Rate:0.70%

Dividend:- -

Dividend Rate:- -

EPS(TTM):4.37

EPS(LYR):0.1575

ROE:24.30%

ROA:11.52%

PB:4.09

PE(LYR):554.37

Loading ...

Overview Company News Filings

Incyte Reports Positive Data for Hidradenitis Suppurativa Treatment

MT Newswires Live

Incyte announces new data from STOP-HS clinical trial program at EADV

Incyte Corp - Nearly 60% of Patients Achieved Hiscr50 at Week 24

THOMSON REUTERS

Incyte Announces New 24-Week Phase 3 Data From the Stop-Hs Clinical Trial Program of Povorcitinib in Hidradenitis Suppurativa at Eadv 2025

THOMSON REUTERS

Incyte Corp. Stock Slips 3.6%, Underperforms Market

Wolfe Research Hikes Incyte's Price Target to $102 From $84

MT Newswires Live

Incyte Corporation Unveils Promising Phase 3 Clinical Trial Results for Povorcitinib at EADV 2025 Congress

Biotech Sector Shows No Signs of Slowing. 3 Stocks That Make the Grade. -- Barrons.com

Bicycle Therapeutics Announces New Board Appointments, Welcoming Roger Dansey and Hervé Hoppenot to Strengthen Leadership

Incyte Corp. Stock Underperforms Thursday When Compared To Competitors

Sheila A. Denton, EVP & General Counsel, Reports Disposal of Incyte Corp Common Shares

Incyte Is Maintained at Buy by B of A Securities

Incyte Corp. Stock Outperforms Competitors On Strong Trading Day

Incyte Corp. Stock Outperforms Competitors On Strong Trading Day

Incyte Corporation Files Initial Statement of Beneficial Ownership for Ramitpal K. Basi, EVP of Human Resources

BRIEF-Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Incyte Corporation Announces New Equity Inducement Awards for Executive VP Soni Basi Under 2024 Stock Incentive Plan

Actuate Therapeutics Announces New Phase 1b Trial of Elra in Combination with Retifanlimab and mFOLFIRINOX for Advanced Pancreatic Cancer

BRIEF-Incyte Names Soni Basi As Executive Vice President And Chief Human Resources Officer

Incyte Corporation Appoints Soni Basi as New Executive Vice President and Chief Human Resources Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/INCY/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INCY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INCY\",,,,,undefined,":{"symbol":"INCY","market":"US","secType":"STK","nameCN":"Incyte","latestPrice":87.3,"timestamp":1761076800000,"preClose":86.17,"halted":0,"volume":1136976,"hourTrading":{"tag":"盘后","latestPrice":87.3,"preClose":87.3,"latestTime":"18:53 EDT","volume":60154,"amount":5251550.3902,"timestamp":1761087202485},"delay":0,"floatShares":163042517,"shares":195276145,"eps":4.368241,"marketStatus":"Closed","change":1.13,"latestTime":"10-21 16:00:00 EDT","open":85.65,"high":87.48,"low":85.55,"amount":98912182.17984,"amplitude":0.022398,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.368241,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1761120000000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":86.17,"preHourTrading":{"tag":"盘前","latestPrice":85.65,"preClose":86.17,"latestTime":"09:29 EDT","volume":323,"amount":27791.892229999998,"timestamp":1761053399999},"postHourTrading":{"tag":"盘后","latestPrice":87.3,"preClose":87.3,"latestTime":"18:53 EDT","volume":60154,"amount":5251550.3902,"timestamp":1761087202485},"volumeRatio":0.503768,"impliedVol":0.3928,"impliedVolPercentile":0.452},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INCY\",,,,,undefined,":{"symbol":"INCY","floatShares":163042517,"roa":"11.52%","roe":"24.30%","lyrEps":0.157476,"volumeRatio":0.503768,"shares":195276145,"dividePrice":0,"high":87.48,"amplitude":0.022398,"preClose":86.17,"low":85.55,"week52Low":53.56,"pbRate":"4.09","psRate":"3.72","week52High":92.86,"institutionHeld":0.8966,"latestPrice":87.3,"eps":4.368241,"divideRate":0,"volume":1136976,"delay":0,"ttmEps":4.368241,"open":85.65,"prevYearClose":69.07,"prevWeekClose":87.57,"prevMonthClose":84.81,"prevQuarterClose":84.81,"fiveDayClose":85.96,"twentyDayClose":84.54,"sixtyDayClose":70.16,"earningDate":1761580800000,"earningTime":"盘前"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INCY\",params:#limit:5,,,undefined,":[{"date":"2025-10-28","symbol":"INCY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":1.38,"defaultRemindTime":1761638400000,"name":null,"time":"Pre-Market","dateTimestamp":1761624000000,"actualEps":null},{"market":"US","date":"2025-07-29","symbol":"INCY","fiscalQuarterEnding":"2025/06","expectedEps":1.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1753761600000,"reportTimeType":"pre","actualEps":1.31},{"market":"US","date":"2025-04-29","symbol":"INCY","fiscalQuarterEnding":"2025/03","expectedEps":0.75,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1745899200000,"reportTimeType":"pre","actualEps":0.89},{"market":"US","date":"2025-02-10","symbol":"INCY","fiscalQuarterEnding":"2024/12","expectedEps":1.29,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739163600000,"reportTimeType":"pre","actualEps":1.09},{"market":"US","date":"2024-10-29","symbol":"INCY","fiscalQuarterEnding":"2024/09","expectedEps":0.88,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730174400000,"reportTimeType":"pre","actualEps":0.73}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INCY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INCY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2222,"buy":0.1481,"hold":0.5926,"sell":0.037,"strongSell":0,"meanLabel":"BUY","meanPercent":0.1481,"analysts":27,"updateTime":1759896000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INCY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INCY","date":"2025-10-20","current":19.985161,"percent":0.355049,"low":-104.400232,"twenty":17.338716,"median":30.24819,"eighty":52.992543,"high":648.145308,"avg":90.612112,"sd":169.89185,"marketCap":17100332017},"quantilePoints":[{"date":"2020-10-23","current":-102.660419,"twenty":-240.25629,"median":-61.366981,"eighty":138.728728,"marketCap":19615120933},{"date":"2020-10-30","current":-99.169347,"twenty":-240.25629,"median":-61.366981,"eighty":138.728728,"marketCap":18948088724},{"date":"2020-11-06","current":-54.431207,"twenty":-238.00085,"median":-60.917493,"eighty":138.728728,"marketCap":18209524883},{"date":"2020-11-13","current":-54.025346,"twenty":-236.748996,"median":-60.220946,"eighty":138.728728,"marketCap":18073747307},{"date":"2020-11-20","current":-53.632577,"twenty":-235.737346,"median":-59.448784,"eighty":138.728728,"marketCap":17942349653},{"date":"2020-11-27","current":-54.496669,"twenty":-235.092429,"median":-59.088741,"eighty":138.728728,"marketCap":18231424492},{"date":"2020-12-04","current":-54.424661,"twenty":-231.552095,"median":-58.79606,"eighty":138.728728,"marketCap":18207334922},{"date":"2020-12-11","current":-53.22017,"twenty":-230.49601,"median":-58.466762,"eighty":138.728728,"marketCap":17804382117},{"date":"2020-12-18","current":-57.828657,"twenty":-227.269242,"median":-58.139583,"eighty":138.728728,"marketCap":19346114590},{"date":"2020-12-24","current":-57.193681,"twenty":-226.375608,"median":-57.840998,"eighty":138.728728,"marketCap":19133688383},{"date":"2020-12-31","current":-56.938381,"twenty":-225.257464,"median":-57.629891,"eighty":138.728728,"marketCap":19048279908},{"date":"2021-01-08","current":-61.422491,"twenty":-224.421058,"median":-57.561475,"eighty":138.728728,"marketCap":20548403124},{"date":"2021-01-15","current":-59.281902,"twenty":-222.691017,"median":-57.561475,"eighty":138.728728,"marketCap":19832285910},{"date":"2021-01-22","current":-64.080227,"twenty":-221.542059,"median":-57.561475,"eighty":138.728728,"marketCap":21437527250},{"date":"2021-01-29","current":-58.751664,"twenty":-217.425457,"median":-57.561475,"eighty":138.728728,"marketCap":19654899077},{"date":"2021-02-05","current":-59.072425,"twenty":-192.069736,"median":-57.561475,"eighty":138.728728,"marketCap":19762207161},{"date":"2021-02-12","current":-62.693578,"twenty":-158.640962,"median":-57.561475,"eighty":138.728728,"marketCap":18538302884},{"date":"2021-02-19","current":-59.879523,"twenty":-157.272898,"median":-57.561475,"eighty":138.728728,"marketCap":17706195248},{"date":"2021-02-26","current":-58.481789,"twenty":-155.620306,"median":-57.561475,"eighty":138.728728,"marketCap":17292889474},{"date":"2021-03-05","current":-59.67135,"twenty":-153.451761,"median":-57.511438,"eighty":138.728728,"marketCap":17644639069},{"date":"2021-03-12","current":-58.742005,"twenty":-151.55119,"median":-57.511438,"eighty":138.728728,"marketCap":17369834697},{"date":"2021-03-19","current":-59.009656,"twenty":-147.610696,"median":-57.511438,"eighty":138.728728,"marketCap":17448978356},{"date":"2021-03-26","current":-60.779128,"twenty":-145.501961,"median":-57.535851,"eighty":138.728728,"marketCap":17972205879},{"date":"2021-04-01","current":-61.715907,"twenty":-144.624845,"median":-57.535851,"eighty":138.728728,"marketCap":18249208685},{"date":"2021-04-09","current":-59.448307,"twenty":-143.480065,"median":-57.511438,"eighty":138.728728,"marketCap":17578686020},{"date":"2021-04-16","current":-61.470561,"twenty":-142.437133,"median":-57.511438,"eighty":138.728728,"marketCap":18176660331},{"date":"2021-04-23","current":-63.636305,"twenty":-140.864214,"median":-57.511438,"eighty":138.728728,"marketCap":18817064417},{"date":"2021-04-30","current":-63.487587,"twenty":-139.050719,"median":-57.511438,"eighty":138.728728,"marketCap":18773089038},{"date":"2021-05-07","current":38.029737,"twenty":-138.140751,"median":-57.417418,"eighty":138.728728,"marketCap":18196468486},{"date":"2021-05-14","current":37.974581,"twenty":-137.538187,"median":-57.041687,"eighty":138.728728,"marketCap":18170077669},{"date":"2021-05-21","current":38.038929,"twenty":-136.154034,"median":-56.859827,"eighty":138.728728,"marketCap":18200866956},{"date":"2021-05-28","current":38.507751,"twenty":-134.962092,"median":-56.671737,"eighty":138.728728,"marketCap":18425188903},{"date":"2021-06-04","current":38.300918,"twenty":-134.368461,"median":-56.473605,"eighty":138.728728,"marketCap":18326223338},{"date":"2021-06-11","current":37.956196,"twenty":-133.781698,"median":-56.211759,"eighty":138.728728,"marketCap":18161280730},{"date":"2021-06-18","current":38.590485,"twenty":-133.212304,"median":-55.917182,"eighty":138.728728,"marketCap":18464775128},{"date":"2021-06-25","current":39.909621,"twenty":-131.986896,"median":-55.561887,"eighty":138.728728,"marketCap":19095955507},{"date":"2021-07-02","current":38.415826,"twenty":-131.334231,"median":-55.337977,"eighty":138.728728,"marketCap":18381204207},{"date":"2021-07-09","current":37.707996,"twenty":-130.920252,"median":-54.86823,"eighty":138.728728,"marketCap":18042522053},{"date":"2021-07-16","current":36.002771,"twenty":-129.331126,"median":-54.431207,"eighty":138.728728,"marketCap":17226605953},{"date":"2021-07-23","current":36.448612,"twenty":-128.489296,"median":-54.267553,"eighty":138.728728,"marketCap":17439931726},{"date":"2021-07-30","current":35.552334,"twenty":-127.966687,"median":-54.053184,"eighty":138.728728,"marketCap":17011080945},{"date":"2021-08-06","current":49.904723,"twenty":-127.053631,"median":-53.781502,"eighty":138.728728,"marketCap":16849731024},{"date":"2021-08-13","current":48.053736,"twenty":-126.920152,"median":-53.75838,"eighty":137.245403,"marketCap":16224767213},{"date":"2021-08-20","current":48.98904,"twenty":-126.920152,"median":-53.75838,"eighty":135.125566,"marketCap":16540561648},{"date":"2021-08-27","current":49.499207,"twenty":-126.920152,"median":-53.75838,"eighty":133.981527,"marketCap":16712813157},{"date":"2021-09-03","current":49.767371,"twenty":-126.920152,"median":-53.75838,"eighty":132.851508,"marketCap":16803355618},{"date":"2021-09-10","current":46.516696,"twenty":-126.920152,"median":-53.75838,"eighty":131.356968,"marketCap":15705804331},{"date":"2021-09-17","current":49.701965,"twenty":-126.920152,"median":-53.75838,"eighty":73.50992,"marketCap":16781272091},{"date":"2021-09-24","current":45.130091,"twenty":-126.920152,"median":-53.75838,"eighty":72.160274,"marketCap":15237633561},{"date":"2021-10-01","current":44.613384,"twenty":-126.920152,"median":-53.75838,"eighty":71.599051,"marketCap":15063173698},{"date":"2021-10-08","current":43.095966,"twenty":-126.920152,"median":-53.75838,"eighty":70.390135,"marketCap":14550835874},{"date":"2021-10-15","current":42.880127,"twenty":-126.920152,"median":-53.75838,"eighty":69.308384,"marketCap":14477960235},{"date":"2021-10-22","current":43.03056,"twenty":-126.920152,"median":-53.75838,"eighty":68.891282,"marketCap":14528752347},{"date":"2021-10-29","current":43.808891,"twenty":-126.920152,"median":-53.75838,"eighty":68.326669,"marketCap":14791546317},{"date":"2021-11-05","current":28.040026,"twenty":-126.321891,"median":-53.279085,"eighty":68.258847,"marketCap":14989637337},{"date":"2021-11-12","current":27.110317,"twenty":-125.553074,"median":-52.997601,"eighty":68.258847,"marketCap":14492633446},{"date":"2021-11-19","current":26.655793,"twenty":-125.039639,"median":-47.426815,"eighty":68.258847,"marketCap":14249653767},{"date":"2021-11-26","current":28.254893,"twenty":-123.924854,"median":-46.283755,"eighty":68.258847,"marketCap":15104500458},{"date":"2021-12-03","current":27.180562,"twenty":-122.424514,"median":-43.300979,"eighty":68.258847,"marketCap":14530184852},{"date":"2021-12-10","current":27.023544,"twenty":-120.541483,"median":-41.894137,"eighty":68.258847,"marketCap":14446246417},{"date":"2021-12-17","current":30.118443,"twenty":-119.13698,"median":26.841735,"eighty":68.258847,"marketCap":16100717146},{"date":"2021-12-23","current":30.358101,"twenty":-115.775745,"median":26.911979,"eighty":68.258847,"marketCap":16228833704},{"date":"2021-12-31","current":30.329177,"twenty":-112.581547,"median":27.15577,"eighty":68.258847,"marketCap":16213371361},{"date":"2022-01-07","current":30.242404,"twenty":-111.158033,"median":27.511125,"eighty":68.252065,"marketCap":16166984331},{"date":"2022-01-14","current":30.940719,"twenty":-109.706662,"median":27.854084,"eighty":68.252065,"marketCap":16540289475},{"date":"2022-01-21","current":30.90353,"twenty":-109.122909,"median":28.14746,"eighty":68.252065,"marketCap":16520409320},{"date":"2022-01-28","current":30.672136,"twenty":-107.744794,"median":29.62673,"eighty":68.252065,"marketCap":16396710574},{"date":"2022-02-04","current":30.035802,"twenty":-106.666568,"median":30.077123,"eighty":68.252065,"marketCap":16056539022},{"date":"2022-02-11","current":15.576603,"twenty":-105.677621,"median":30.151499,"eighty":68.252065,"marketCap":14775669617},{"date":"2022-02-18","current":15.989584,"twenty":-103.869131,"median":30.151499,"eighty":68.252065,"marketCap":15167415202},{"date":"2022-02-25","current":15.963918,"twenty":-103.539483,"median":30.151499,"eighty":68.252065,"marketCap":15143069431},{"date":"2022-03-04","current":16.344234,"twenty":-102.763434,"median":30.151499,"eighty":68.252065,"marketCap":15503829489},{"date":"2022-03-11","current":17.251858,"twenty":-101.447128,"median":30.151499,"eighty":68.252065,"marketCap":16364784474},{"date":"2022-03-18","current":17.545844,"twenty":-100.506256,"median":30.151499,"eighty":68.252065,"marketCap":16643654212},{"date":"2022-03-25","current":18.306475,"twenty":-99.373088,"median":30.151499,"eighty":68.252065,"marketCap":17365174328},{"date":"2022-04-01","current":18.651792,"twenty":-97.445558,"median":30.151499,"eighty":68.252065,"marketCap":17692735608},{"date":"2022-04-08","current":19.407757,"twenty":-93.439406,"median":30.151499,"eighty":68.252065,"marketCap":18409829221},{"date":"2022-04-14","current":19.071772,"twenty":-91.423658,"median":30.151499,"eighty":68.252065,"marketCap":18091120948},{"date":"2022-04-22","current":17.867829,"twenty":-89.542294,"median":30.151499,"eighty":68.252065,"marketCap":16949082973},{"date":"2022-04-29","current":17.489847,"twenty":-88.994619,"median":30.151499,"eighty":68.252065,"marketCap":16590536167},{"date":"2022-05-06","current":17.838131,"twenty":-88.883056,"median":30.023406,"eighty":68.021473,"marketCap":16643654212},{"date":"2022-05-13","current":17.781404,"twenty":-88.883056,"median":29.345751,"eighty":67.499248,"marketCap":16590725323},{"date":"2022-05-20","current":17.776656,"twenty":-88.883056,"median":28.029696,"eighty":66.763386,"marketCap":16586295223},{"date":"2022-05-27","current":18.325054,"twenty":-88.883056,"median":27.587568,"eighty":65.832537,"marketCap":17097971799},{"date":"2022-06-03","current":17.558246,"twenty":-88.883056,"median":27.482201,"eighty":65.113631,"marketCap":16382510613},{"date":"2022-06-10","current":16.713095,"twenty":-88.883056,"median":27.06693,"eighty":64.292991,"marketCap":15593952774},{"date":"2022-06-17","current":16.919635,"twenty":-88.883056,"median":26.885121,"eighty":60.086945,"marketCap":15786662133},{"date":"2022-06-24","current":18.562456,"twenty":-88.883056,"median":26.36655,"eighty":58.867713,"marketCap":17319476810},{"date":"2022-07-01","current":18.439007,"twenty":-88.883056,"median":19.147526,"eighty":58.036609,"marketCap":17204294204},{"date":"2022-07-08","current":19.106106,"twenty":-88.883056,"median":19.102104,"eighty":57.517697,"marketCap":17826723285},{"date":"2022-07-15","current":18.999276,"twenty":-88.883056,"median":18.925681,"eighty":56.936909,"marketCap":17727046030},{"date":"2022-07-22","current":19.205815,"twenty":-88.883056,"median":18.904315,"eighty":56.208463,"marketCap":17919755389},{"date":"2022-07-29","current":18.441381,"twenty":-88.883056,"median":18.878115,"eighty":55.366109,"marketCap":17206509254},{"date":"2022-08-05","current":16.913825,"twenty":-88.883056,"median":18.721515,"eighty":55.122825,"marketCap":15983801593},{"date":"2022-08-12","current":17.415237,"twenty":-88.883056,"median":18.588795,"eighty":54.717821,"marketCap":16457642683},{"date":"2022-08-19","current":17.544692,"twenty":-88.883056,"median":18.439007,"eighty":54.475943,"marketCap":16579979532},{"date":"2022-08-26","current":16.824451,"twenty":-88.883056,"median":18.331526,"eighty":53.5014,"marketCap":15899341789},{"date":"2022-09-02","current":16.525528,"twenty":-88.883056,"median":18.243478,"eighty":52.597171,"marketCap":15616854883},{"date":"2022-09-09","current":16.99392,"twenty":-88.883056,"median":18.047294,"eighty":52.079665,"marketCap":16059491847},{"date":"2022-09-16","current":16.200713,"twenty":-88.883056,"median":17.954707,"eighty":50.829148,"marketCap":15309900607},{"date":"2022-09-23","current":15.74409,"twenty":-88.883056,"median":17.867829,"eighty":50.44787,"marketCap":14878385175},{"date":"2022-09-30","current":15.685246,"twenty":-88.883056,"median":17.800396,"eighty":50.239968,"marketCap":14822777516},{"date":"2022-10-07","current":16.10421,"twenty":-88.883056,"median":17.744168,"eighty":50.010331,"marketCap":15218704046},{"date":"2022-10-14","current":16.264264,"twenty":-88.883056,"median":17.643549,"eighty":49.808517,"marketCap":15369956878},{"date":"2022-10-21","current":16.612615,"twenty":-88.883056,"median":17.544692,"eighty":49.590775,"marketCap":15699154218},{"date":"2022-10-28","current":17.558814,"twenty":-88.883056,"median":17.448189,"eighty":49.403714,"marketCap":16593325371},{"date":"2022-11-04","current":19.630562,"twenty":-88.883056,"median":17.448189,"eighty":49.110861,"marketCap":17197353676},{"date":"2022-11-11","current":19.688971,"twenty":-88.883056,"median":17.448189,"eighty":48.910553,"marketCap":17248523034},{"date":"2022-11-18","current":19.668655,"twenty":-88.883056,"median":17.448189,"eighty":48.59263,"marketCap":17230724996},{"date":"2022-11-25","current":19.874357,"twenty":-88.883056,"median":17.448189,"eighty":48.454449,"marketCap":17410930125},{"date":"2022-12-02","current":21.111107,"twenty":-88.883056,"median":17.448189,"eighty":48.041963,"marketCap":18494385654},{"date":"2022-12-09","current":20.910485,"twenty":-88.883056,"median":17.448189,"eighty":47.59851,"marketCap":18318630035},{"date":"2022-12-16","current":20.831759,"twenty":-88.883056,"median":17.448189,"eighty":47.263641,"marketCap":18249662640},{"date":"2022-12-23","current":20.661611,"twenty":-88.883056,"median":17.448189,"eighty":47.016101,"marketCap":18100604076},{"date":"2022-12-30","current":20.3975,"twenty":-88.883056,"median":17.448189,"eighty":46.554796,"marketCap":17869229589},{"date":"2023-01-06","current":20.537174,"twenty":-88.211139,"median":17.541628,"eighty":46.554796,"marketCap":17991591097},{"date":"2023-01-13","current":20.527016,"twenty":-87.440338,"median":17.558814,"eighty":46.554796,"marketCap":17982692078},{"date":"2023-01-20","current":21.128884,"twenty":-86.920554,"median":17.688817,"eighty":46.554796,"marketCap":18509958937},{"date":"2023-01-27","current":21.763766,"twenty":-86.375415,"median":17.776656,"eighty":46.554796,"marketCap":19066147607},{"date":"2023-02-03","current":21.233005,"twenty":-85.224284,"median":17.831258,"eighty":46.554796,"marketCap":18601173879},{"date":"2023-02-10","current":51.876379,"twenty":-84.628433,"median":17.926219,"eighty":47.016101,"marketCap":17672207326},{"date":"2023-02-17","current":51.706207,"twenty":-84.430663,"median":18.016432,"eighty":47.263641,"marketCap":17614236422},{"date":"2023-02-24","current":50.410279,"twenty":-84.430663,"median":18.075782,"eighty":47.465954,"marketCap":17172765686},{"date":"2023-03-03","current":50.763714,"twenty":-84.430663,"median":18.306475,"eighty":47.986899,"marketCap":17293166796},{"date":"2023-03-10","current":47.131189,"twenty":-84.430663,"median":18.365412,"eighty":48.204376,"marketCap":16055710946},{"date":"2023-03-17","current":48.184949,"twenty":-84.430663,"median":18.530464,"eighty":48.335268,"marketCap":16414684625},{"date":"2023-03-24","current":45.966163,"twenty":-84.430663,"median":18.651792,"eighty":48.401919,"marketCap":15658833214},{"date":"2023-03-31","current":47.301362,"twenty":-84.412914,"median":18.778445,"eighty":48.397883,"marketCap":16113681850},{"date":"2023-04-06","current":48.28967,"twenty":-84.412914,"median":18.882782,"eighty":48.397883,"marketCap":16450359028},{"date":"2023-04-14","current":49.304159,"twenty":-84.430663,"median":19.071772,"eighty":48.454449,"marketCap":16795954805},{"date":"2023-04-21","current":48.335486,"twenty":-84.430663,"median":19.139343,"eighty":48.50111,"marketCap":16465966579},{"date":"2023-04-28","current":48.204584,"twenty":-84.430663,"median":19.205815,"eighty":48.553797,"marketCap":16421373575},{"date":"2023-05-05","current":45.522611,"twenty":-84.430663,"median":19.457874,"eighty":48.598963,"marketCap":14766214974},{"date":"2023-05-12","current":44.133343,"twenty":-84.430663,"median":19.577232,"eighty":48.598963,"marketCap":14315576596},{"date":"2023-05-19","current":43.761954,"twenty":-65.975243,"median":19.668655,"eighty":48.598963,"marketCap":14195108910},{"date":"2023-05-26","current":43.239259,"twenty":-63.609535,"median":19.757538,"eighty":48.598963,"marketCap":14025561798},{"date":"2023-06-02","current":42.30391,"twenty":-63.241519,"median":19.876896,"eighty":48.598963,"marketCap":13722161702},{"date":"2023-06-09","current":42.30391,"twenty":-62.97873,"median":20.184179,"eighty":48.598963,"marketCap":13722161702},{"date":"2023-06-16","current":43.03981,"twenty":-62.654259,"median":20.2337,"eighty":48.609617,"marketCap":13960866189},{"date":"2023-06-23","current":42.579013,"twenty":-62.203628,"median":20.44829,"eighty":48.620272,"marketCap":13811397024},{"date":"2023-06-30","current":42.537748,"twenty":-61.715907,"median":20.562569,"eighty":48.630926,"marketCap":13798011726},{"date":"2023-07-07","current":43.232382,"twenty":-61.507591,"median":20.746685,"eighty":48.630926,"marketCap":14023330915},{"date":"2023-07-14","current":42.599646,"twenty":-61.285022,"median":20.93842,"eighty":48.630926,"marketCap":13818089673},{"date":"2023-07-21","current":44.023302,"twenty":-60.953261,"median":21.128884,"eighty":48.639436,"marketCap":14279882467},{"date":"2023-07-28","current":43.108586,"twenty":-60.731546,"median":21.301572,"eighty":48.639436,"marketCap":13983175020},{"date":"2023-08-04","current":39.731882,"twenty":-60.438616,"median":21.456483,"eighty":48.639436,"marketCap":14561218421},{"date":"2023-08-11","current":40.05595,"twenty":-60.194533,"median":21.842492,"eighty":48.639436,"marketCap":14679984899},{"date":"2023-08-18","current":39.261068,"twenty":-59.937514,"median":26.841735,"eighty":48.639436,"marketCap":14388670895},{"date":"2023-08-25","current":39.273297,"twenty":-59.653506,"median":26.936772,"eighty":48.639436,"marketCap":14393152649},{"date":"2023-09-01","current":39.456731,"twenty":-59.512326,"median":27.180562,"eighty":48.639436,"marketCap":14460378958},{"date":"2023-09-08","current":38.796367,"twenty":-59.369499,"median":27.531785,"eighty":48.639436,"marketCap":14218364247},{"date":"2023-09-15","current":38.814711,"twenty":-59.210021,"median":27.887141,"eighty":48.639436,"marketCap":14225086878},{"date":"2023-09-22","current":35.959249,"twenty":-58.96037,"median":28.341665,"eighty":48.639436,"marketCap":13178597342},{"date":"2023-09-29","current":35.83696,"twenty":-58.783922,"median":29.746559,"eighty":48.639436,"marketCap":13133779803},{"date":"2023-10-06","current":35.959249,"twenty":-58.648658,"median":30.184555,"eighty":48.639436,"marketCap":13178597342},{"date":"2023-10-13","current":34.589606,"twenty":-58.325093,"median":30.329177,"eighty":48.639436,"marketCap":12676640906},{"date":"2023-10-20","current":34.020959,"twenty":-58.123791,"median":30.432478,"eighty":48.639436,"marketCap":12468239349},{"date":"2023-10-23","current":33.709121,"twenty":-58.104138,"median":30.444874,"eighty":48.639436,"marketCap":12353954625},{"date":"2023-11-03","current":28.460509,"twenty":-57.44054,"median":30.568835,"eighty":48.673477,"marketCap":12095175574},{"date":"2023-11-10","current":27.695867,"twenty":-57.041687,"median":30.568835,"eighty":48.673477,"marketCap":11770217179},{"date":"2023-11-17","current":28.471056,"twenty":-56.859827,"median":30.568835,"eighty":48.673477,"marketCap":12099657759},{"date":"2023-11-24","current":28.339221,"twenty":-56.671737,"median":30.568835,"eighty":48.673477,"marketCap":12043630450},{"date":"2023-12-01","current":28.655625,"twenty":-56.44742,"median":30.568835,"eighty":48.673477,"marketCap":12178095992},{"date":"2023-12-08","current":29.09859,"twenty":-55.919657,"median":30.566769,"eighty":48.664967,"marketCap":12366347752},{"date":"2023-12-15","current":33.665349,"twenty":-55.635877,"median":30.642536,"eighty":48.664967,"marketCap":14307133753},{"date":"2023-12-22","current":32.531569,"twenty":-55.314549,"median":30.804361,"eighty":48.664967,"marketCap":13825298892},{"date":"2023-12-29","current":33.080002,"twenty":-54.86823,"median":30.90353,"eighty":48.673477,"marketCap":14058372499},{"date":"2024-01-05","current":35.115533,"twenty":-54.444299,"median":31.099803,"eighty":48.675257,"marketCap":14923434158},{"date":"2024-01-12","current":33.280391,"twenty":-54.278027,"median":32.355824,"eighty":48.675257,"marketCap":14143534010},{"date":"2024-01-19","current":32.262626,"twenty":-54.097036,"median":32.479514,"eighty":48.677037,"marketCap":13711003180},{"date":"2024-01-26","current":32.125518,"twenty":-53.861692,"median":32.505541,"eighty":48.675257,"marketCap":13652734778},{"date":"2024-02-02","current":31.197401,"twenty":-53.506891,"median":32.505541,"eighty":48.675257,"marketCap":13258302520},{"date":"2024-02-09","current":30.24819,"twenty":-53.144235,"median":32.505541,"eighty":48.675257,"marketCap":12854905891},{"date":"2024-02-16","current":22.155837,"twenty":-52.564683,"median":32.440893,"eighty":48.588308,"marketCap":13240305768},{"date":"2024-02-23","current":22.884721,"twenty":-52.564683,"median":32.304813,"eighty":48.499532,"marketCap":13675886456},{"date":"2024-03-01","current":21.926651,"twenty":-52.492457,"median":32.083331,"eighty":48.414027,"marketCap":13103344830},{"date":"2024-03-08","current":22.178379,"twenty":-52.492457,"median":31.44525,"eighty":48.309305,"marketCap":13253777335},{"date":"2024-03-15","current":21.99428,"twenty":-52.492457,"median":30.994435,"eighty":48.204584,"marketCap":13143759533},{"date":"2024-03-22","current":21.686194,"twenty":-52.492457,"median":30.891134,"eighty":48.099863,"marketCap":12959648108},{"date":"2024-03-28","current":21.460766,"twenty":-52.492457,"median":30.738249,"eighty":47.955422,"marketCap":12824932431},{"date":"2024-04-05","current":20.660496,"twenty":-52.564683,"median":30.61994,"eighty":47.58148,"marketCap":12346691778},{"date":"2024-04-12","current":20.634196,"twenty":-52.564683,"median":30.4676,"eighty":47.410327,"marketCap":12330974949},{"date":"2024-04-19","current":19.845197,"twenty":-52.564683,"median":30.368431,"eighty":47.294817,"marketCap":11859470080},{"date":"2024-04-26","current":19.229027,"twenty":-52.492457,"median":30.308517,"eighty":47.22407,"marketCap":11491247231},{"date":"2024-05-03","current":15.991635,"twenty":-52.492457,"median":30.184555,"eighty":46.833129,"marketCap":11920868470},{"date":"2024-05-10","current":16.115134,"twenty":-52.492457,"median":29.750691,"eighty":46.53527,"marketCap":12012930178},{"date":"2024-05-17","current":17.127225,"twenty":-52.492457,"median":29.110225,"eighty":46.400692,"marketCap":12767387101},{"date":"2024-05-24","current":17.329127,"twenty":-52.492457,"median":28.924568,"eighty":45.817215,"marketCap":12917894069},{"date":"2024-05-31","current":17.283882,"twenty":-52.492457,"median":28.845467,"eighty":45.631052,"marketCap":12884165886},{"date":"2024-06-07","current":17.6187,"twenty":-52.492457,"median":28.618711,"eighty":45.300146,"marketCap":13133754440},{"date":"2024-06-14","current":18.909713,"twenty":-52.564683,"median":28.448595,"eighty":45.014977,"marketCap":14096131927},{"date":"2024-06-21","current":18.810172,"twenty":-52.636909,"median":28.254893,"eighty":44.814222,"marketCap":14021929925},{"date":"2024-06-28","current":18.505517,"twenty":-52.853586,"median":28.029696,"eighty":44.545997,"marketCap":13794826826},{"date":"2024-07-05","current":17.392472,"twenty":-52.853586,"median":27.883789,"eighty":44.45557,"marketCap":12965113525},{"date":"2024-07-12","current":18.789057,"twenty":-52.853586,"median":27.625789,"eighty":44.208996,"marketCap":14006190106},{"date":"2024-07-15","current":19.202302,"twenty":-52.853586,"median":27.587568,"eighty":44.133343,"marketCap":14314240843},{"date":"2024-08-02","current":127.521095,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12407164899},{"date":"2024-08-09","current":122.295145,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":11898706108},{"date":"2024-08-16","current":122.097192,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":11879446305},{"date":"2024-08-23","current":124.749758,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12137527661},{"date":"2024-08-30","current":130.470589,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12694135959},{"date":"2024-09-06","current":124.630986,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12125971779},{"date":"2024-09-13","current":125.422797,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12203010990},{"date":"2024-09-20","current":132.271958,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12869400164},{"date":"2024-09-27","current":128.926558,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12543909498},{"date":"2024-10-04","current":132.707454,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12911771730},{"date":"2024-10-11","current":129.401645,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12590133024},{"date":"2024-10-18","current":131.499943,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12794286933},{"date":"2024-10-25","current":129.144306,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12565095281},{"date":"2024-10-31","current":438.477708,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":14242632908},{"date":"2024-11-08","current":488.35729,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":15862821502},{"date":"2024-11-15","current":461.01545,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":14974703854},{"date":"2024-11-22","current":417.482022,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13560651027},{"date":"2024-11-29","current":442.392158,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":14369782072},{"date":"2024-12-06","current":444.349383,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":14433356655},{"date":"2024-12-13","current":420.091655,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13645417136},{"date":"2024-12-20","current":397.731842,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":12919125697},{"date":"2024-12-27","current":412.559304,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13400751320},{"date":"2025-01-03","current":412.381375,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13394971812},{"date":"2025-01-10","current":433.73292,"twenty":-53.207078,"median":27.180562,"eighty":43.823852,"marketCap":14088512709},{"date":"2025-01-17","current":429.81847,"twenty":-53.207078,"median":27.180562,"eighty":44.119588,"marketCap":13961363545},{"date":"2025-01-24","current":430.174329,"twenty":-53.207078,"median":27.180562,"eighty":44.284649,"marketCap":13972922559},{"date":"2025-01-31","current":437.52875,"twenty":-53.207078,"median":27.180562,"eighty":44.759202,"marketCap":14211808868},{"date":"2025-02-07","current":444.527312,"twenty":-53.207078,"median":27.180562,"eighty":45.130091,"marketCap":14439136162},{"date":"2025-02-14","current":415.411306,"twenty":-53.207078,"median":27.180562,"eighty":45.522611,"marketCap":13548639743},{"date":"2025-02-21","current":423.540337,"twenty":-53.207078,"median":27.180562,"eighty":45.966163,"marketCap":13813768103},{"date":"2025-02-28","current":434.220817,"twenty":-53.207078,"median":27.180562,"eighty":46.516696,"marketCap":14162111933},{"date":"2025-03-07","current":415.885994,"twenty":-53.209696,"median":27.168166,"eighty":47.237523,"marketCap":13564121691},{"date":"2025-03-14","current":401.764027,"twenty":-53.209696,"median":27.168166,"eighty":47.318409,"marketCap":13103533738},{"date":"2025-03-21","current":359.457462,"twenty":-53.209696,"median":27.168166,"eighty":47.54487,"marketCap":11723705123},{"date":"2025-03-28","current":360.050822,"twenty":-53.209696,"median":27.168166,"eighty":47.729411,"marketCap":11743057558},{"date":"2025-04-04","current":370.612629,"twenty":-53.209696,"median":27.168166,"eighty":48.105099,"marketCap":12087530901},{"date":"2025-04-11","current":327.356688,"twenty":-53.207078,"median":27.180562,"eighty":48.204584,"marketCap":10676738389},{"date":"2025-04-17","current":342.546703,"twenty":-53.207078,"median":27.180562,"eighty":48.30276,"marketCap":11172160725},{"date":"2025-04-25","current":349.904367,"twenty":-53.209696,"median":27.168166,"eighty":48.304069,"marketCap":11412130919},{"date":"2025-05-02","current":564.51072,"twenty":-53.209696,"median":27.168166,"eighty":48.393956,"marketCap":12007143006},{"date":"2025-05-09","current":543.579321,"twenty":-52.564683,"median":27.496923,"eighty":48.460691,"marketCap":11561932157},{"date":"2025-05-16","current":571.154163,"twenty":15.632391,"median":27.625789,"eighty":48.737881,"marketCap":12148449057},{"date":"2025-05-23","current":587.080228,"twenty":15.726225,"median":27.883789,"eighty":49.007354,"marketCap":12487196442},{"date":"2025-05-30","current":601.004158,"twenty":15.826258,"median":28.029696,"eighty":49.252879,"marketCap":12783358441},{"date":"2025-06-06","current":611.924888,"twenty":15.885314,"median":28.339221,"eighty":49.434802,"marketCap":13015642362},{"date":"2025-06-13","current":629.944092,"twenty":15.934986,"median":28.478966,"eighty":49.660105,"marketCap":13398910831},{"date":"2025-06-20","current":621.298514,"twenty":15.990815,"median":28.671445,"eighty":49.822312,"marketCap":13215019394},{"date":"2025-06-27","current":644.414059,"twenty":16.096118,"median":28.856014,"eighty":50.382952,"marketCap":13706687026},{"date":"2025-07-03","current":622.936624,"twenty":16.116941,"median":28.993122,"eighty":50.591002,"marketCap":13249861982},{"date":"2025-07-11","current":640.136773,"twenty":16.200713,"median":29.581278,"eighty":51.047771,"marketCap":13615709157},{"date":"2025-07-18","current":627.395921,"twenty":16.252966,"median":30.035802,"eighty":51.822721,"marketCap":13344711249},{"date":"2025-07-25","current":641.501864,"twenty":16.33326,"median":30.242404,"eighty":52.761862,"marketCap":13644744647},{"date":"2025-08-01","current":16.792668,"twenty":16.378635,"median":30.24819,"eighty":52.992543,"marketCap":14624230499},{"date":"2025-08-08","current":17.534873,"twenty":16.546711,"median":30.24819,"eighty":52.992543,"marketCap":15270594539},{"date":"2025-08-15","current":19.319752,"twenty":16.607924,"median":30.24819,"eighty":52.992543,"marketCap":16824992653},{"date":"2025-08-22","current":19.402718,"twenty":16.798469,"median":30.24819,"eighty":52.992543,"marketCap":16897244826},{"date":"2025-08-29","current":18.768144,"twenty":16.870655,"median":30.24819,"eighty":52.992543,"marketCap":16344613336},{"date":"2025-09-05","current":19.158306,"twenty":16.99751,"median":30.268023,"eighty":53.052464,"marketCap":16684393828},{"date":"2025-09-12","current":19.321995,"twenty":17.085907,"median":30.24819,"eighty":52.992543,"marketCap":16826945414},{"date":"2025-09-19","current":19.283875,"twenty":17.161262,"median":30.24819,"eighty":52.992543,"marketCap":16793748470},{"date":"2025-09-26","current":18.310712,"twenty":17.193493,"median":30.24819,"eighty":52.992543,"marketCap":15946250000},{"date":"2025-10-03","current":19.34666,"twenty":17.274387,"median":30.24819,"eighty":52.992543,"marketCap":16848425790},{"date":"2025-10-10","current":19.003586,"twenty":17.291711,"median":30.24819,"eighty":52.992543,"marketCap":16549653288},{"date":"2025-10-17","current":19.577618,"twenty":17.328736,"median":30.24819,"eighty":52.992543,"marketCap":17049560219},{"date":"2025-10-20","current":19.635918,"twenty":17.338716,"median":30.24819,"eighty":52.992543,"marketCap":17100332017}],"updateTime":1761085929056},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INCY\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2568496509","title":"Incyte Reports Positive Data for Hidradenitis Suppurativa Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2568496509","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568496509?lang=en_us&edition=fundamental","pubTime":"2025-09-17 20:35","pubTimestamp":1758112514,"startTime":"0","endTime":"0","summary":"Incyte  on Wednesday reported positive new 24-week interim data from its phase 3 trial evaluating povorcitinib in adult patients with moderate to severe hidradenitis suppurativa.The data showed almost 60% of efficacy-evaluable patients receiving 45 mg or 75 mg of povorcitinib achieved HiSCR50, defined as at least a 50% reduction in the total abscess and inflammatory nodule count.The data support planned regulatory submissions for povorcitinib in Europe and the US in 2025 and early 2026, respectively, the company said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4550","BK4585","BK4139","INCY","BK4532"],"gpt_icon":0},{"id":"2568546446","title":"Incyte announces new data from STOP-HS clinical trial program at EADV","url":"https://stock-news.laohu8.com/highlight/detail?id=2568546446","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568546446?lang=en_us&edition=fundamental","pubTime":"2025-09-17 17:35","pubTimestamp":1758101713,"startTime":"0","endTime":"0","summary":"Incyte (INCY) announced new 24-week interim data evaluating the safety and efficacy of povorcitinib, an oral small-molecule highly-selective JAK1 i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/incyte-announces-new-data-from-stop-hs-clinical-trial-program-at-eadv-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/incyte-announces-new-data-from-stop-hs-clinical-trial-program-at-eadv-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4550","BK4532","BK4139","BK4588","INCY"],"gpt_icon":0},{"id":"2568454650","title":"Incyte Corp - Nearly 60% of Patients Achieved Hiscr50 at Week 24","url":"https://stock-news.laohu8.com/highlight/detail?id=2568454650","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568454650?lang=en_us&edition=fundamental","pubTime":"2025-09-17 13:00","pubTimestamp":1758085201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nTUA6S6XVM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INCY","BK4588","BK4585","BK4139","BK4550","BK4532"],"gpt_icon":0},{"id":"2568245465","title":"Incyte Announces New 24-Week Phase 3 Data From the Stop-Hs Clinical Trial Program of Povorcitinib in Hidradenitis Suppurativa at Eadv 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2568245465","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568245465?lang=en_us&edition=fundamental","pubTime":"2025-09-17 13:00","pubTimestamp":1758085201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nTUA6S6XVM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4585","BK4588","BK4532","INCY","BK4550"],"gpt_icon":0},{"id":"2567904322","title":"Incyte Corp. Stock Slips 3.6%, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2567904322","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567904322?lang=en_us&edition=fundamental","pubTime":"2025-09-13 04:35","pubTimestamp":1757709300,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Incyte Corp. slipped 3.6% to $83.10 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 6,584.29 and the Dow Jones Industrial Average falling 0.6% to 45,834.22.This was the stock's second consecutive day of losses.Incyte Corp. closed 5.6% below its 52-week high of $87.99, which the company reached on September 4th.The stock demonstrated a mixed performance when compared to some of its peers, as Alnylam Pharmaceuticals Inc. fell 0.6% to $465.89, Bio-Techne Corp. fell 3.7% to $51.26, and BioMarin Pharmaceutical Inc. fell 3.26% to $54.09.Trading volume totaled 1.8 million, compared to the 50-day average of 1.7 million.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY"],"gpt_icon":0},{"id":"2566362989","title":"Wolfe Research Hikes Incyte's Price Target to $102 From $84","url":"https://stock-news.laohu8.com/highlight/detail?id=2566362989","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566362989?lang=en_us&edition=fundamental","pubTime":"2025-09-11 01:59","pubTimestamp":1757527189,"startTime":"0","endTime":"0","summary":"Incyte (INCY) has an average rating of overweight and mean price target of $82.40, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INCY"],"gpt_icon":0},{"id":"2566560367","title":"Incyte Corporation Unveils Promising Phase 3 Clinical Trial Results for Povorcitinib at EADV 2025 Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2566560367","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566560367?lang=en_us&edition=fundamental","pubTime":"2025-09-10 19:30","pubTimestamp":1757503826,"startTime":"0","endTime":"0","summary":"Incyte Corporation has announced its upcoming presentation of new data from its dermatology portfolio at the European Association of Dermatology and Venerology  2025 Congress, scheduled from September 17 to 20 in Paris. The presentations will feature key findings from clinical trials involving povorcitinib and ruxolitinib cream. Notably, 24-week interim results from the Phase 3 STOP-HS clinical trial program of povorcitinib in patients with hidradenitis suppurativa will be highlighted in a late-breaking oral presentation. Additionally, efficacy and safety data for ruxolitinib cream in treating prurigo nodularis will be shared, based on pooled results from the Phase 3 TRuE-PN1 and TRuE-PN2 studies. The congress will also cover findings related to vitiligo and the long-term safety of ruxolitinib cream across multiple indications.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely infor","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nNDL55qcmJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY","BK4550","BK4585","BK4532","BK4588","BK4139"],"gpt_icon":0},{"id":"2566612021","title":"Biotech Sector Shows No Signs of Slowing. 3 Stocks That Make the Grade. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2566612021","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566612021?lang=en_us&edition=fundamental","pubTime":"2025-09-10 02:22","pubTimestamp":1757442120,"startTime":"0","endTime":"0","summary":"Biotech stocks are on a winning streak that might just continue through the rest of the year.Last week, the SPDR S&P Biotech exchange-traded fund  surged 6%, contrasting with a 0.8% decline in the broader healthcare space, as measured by the Health Care Select Sector SPDR fund . When the biotech sector shows signs of renewed strength, it often signals a broader risk-on sentiment among investors.The biotech ETF, up 5% in 2025, is poised for its third consecutive annual percent gain in the single digits.Could the sector be gearing up for a meaningful rally into year-end?The daily chart shows technically constructive patterns, starting with a powerful double bottom on May 23 that propelled a breakout surge of over 32%. A subsequent cup base breakout in mid-July set the stage for another bull flag pattern. That gave investors another chance to build up their positions","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","INCY","CRSP","LU0889565916.HKD","BK4611","LU0109394709.USD","BK4556","LU0320765992.SGD","LU1861558580.USD","BK4581","BK4532","LU1861559042.SGD","MRUS","BK4585","BK4588","XLV","BK4139"],"gpt_icon":0},{"id":"2566120634","title":"Bicycle Therapeutics Announces New Board Appointments, Welcoming Roger Dansey and Hervé Hoppenot to Strengthen Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2566120634","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566120634?lang=en_us&edition=fundamental","pubTime":"2025-09-09 04:02","pubTimestamp":1757361745,"startTime":"0","endTime":"0","summary":"Bicycle Therapeutics plc has announced the appointment of Roger Dansey, M.D., and Hervé Hoppenot to its Board of Directors. Roger Dansey brings experience from Pfizer and Seagen, while Hervé Hoppenot brings expertise from Incyte and Novartis Oncology. The company aims to leverage their extensive backgrounds in oncology research and drug development as it progresses with its pipeline of targeted therapies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bicycle Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 08, 2025, and is solely responsible for the information ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nNDLbbP5mN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4599","BK4533","BK4139","LU1066053197.SGD","LU0122379950.USD","BK4585","BK4532","BK4550","BK4592","IE00B19Z3581.USD","SG9999001176.SGD","SG9999003800.SGD","LU0306806265.USD","LU0321505868.SGD","LU0985481810.HKD","IE0002270589.USD","SG9999013999.USD","LU0225771236.USD","LU0321505439.SGD","LU1057294990.SGD","SG9999011175.SGD","LU0225284248.USD","LU1066051498.USD","LU1894683348.USD","SG9999001176.USD","LU1883839398.USD","SG9999002232.USD","LU1894683264.USD","BK4581","IE000M9KFDE8.USD","BCYC","LU0170899867.USD","IE00B19Z3B42.SGD","LU0306807586.USD","IE00BBT3K403.USD","LU0456855351.SGD","SG9999002224.SGD","BK4007","IE00BLSP4452.SGD","LU1023059063.AUD","BK4534","LU0058720904.USD","INCY","BK4588","IE00BLSP4239.USD","LU0289739699.SGD","LU0234572021.USD","SGXZ57979304.SGD"],"gpt_icon":1},{"id":"2565583901","title":"Incyte Corp. Stock Underperforms Thursday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2565583901","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565583901?lang=en_us&edition=fundamental","pubTime":"2025-09-05 05:11","pubTimestamp":1757020260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Incyte Corp.  shed 1.75% to $85.44 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.83% to 6,502.08 and the Dow Jones Industrial Average  rising 0.77% to 45,621.29.The stock's fall snapped a three-day winning streak.Incyte Corp. closed 2.90% short of its 52-week high of $87.99, which the company achieved on September 2nd.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Alnylam Pharmaceuticals Inc.  rose 1.37% to $453.54, Bio-Techne Corp.  fell 0.79% to $52.92, and BioMarin Pharmaceutical Inc.  fell 3.78% to $56.75.Data source: Dow Jones Market Data, FactSet. Data compiled September 4, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY"],"gpt_icon":0},{"id":"2565562300","title":"Sheila A. Denton, EVP & General Counsel, Reports Disposal of Incyte Corp Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2565562300","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565562300?lang=en_us&edition=fundamental","pubTime":"2025-09-05 04:11","pubTimestamp":1757016665,"startTime":"0","endTime":"0","summary":"Sheila A. Denton, EVP & General Counsel of Incyte Corporation, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incyte Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 04, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nNDL6RBH9b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4139","BK4550","BK4585","BK4588","INCY"],"gpt_icon":0},{"id":"2565939304","title":"Incyte Is Maintained at Buy by B of A Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2565939304","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565939304?lang=en_us&edition=fundamental","pubTime":"2025-09-05 02:11","pubTimestamp":1757009460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/INCY/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 04, 2025 14:11 ET (18:11 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY"],"gpt_icon":0},{"id":"2564333053","title":"Incyte Corp. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2564333053","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564333053?lang=en_us&edition=fundamental","pubTime":"2025-09-03 05:12","pubTimestamp":1756847520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Incyte Corp.  rallied 1.62% to $85.98 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.69% to 6,415.54 and Dow Jones Industrial Average  falling 0.55% to 45,295.81.This was the stock's second consecutive day of gains.Incyte Corp. closed 1.44% below its 52-week high of $87.24, which the company reached on August 18th.The stock outperformed some of its competitors Tuesday, as Alnylam Pharmaceuticals Inc.  rose 0.11% to $447.00, Bio-Techne Corp.  fell 2.21% to $53.42, and BioMarin Pharmaceutical Inc.  rose 1.41% to $59.09.Trading volume  eclipsed its 50-day average volume of 1.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 2, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Str","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY"],"gpt_icon":0},{"id":"2562277827","title":"Incyte Corp. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2562277827","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562277827?lang=en_us&edition=fundamental","pubTime":"2025-08-28 05:14","pubTimestamp":1756329240,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Incyte Corp.  inched 1.00% higher to $84.84 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.24% to 6,481.40 and the Dow Jones Industrial Average  rising 0.32% to 45,565.23.The stock's rise snapped a three-day losing streak.Incyte Corp. closed 2.75% below its 52-week high of $87.24, which the company achieved on August 18th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Alnylam Pharmaceuticals Inc.  rose 0.66% to $454.18, Bio-Techne Corp.  fell 1.00% to $56.22, and BioMarin Pharmaceutical Inc.  rose 2.11% to $58.66.Trading volume  remained 348,766 below its 50-day average volume of 1.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 27, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is pu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY"],"gpt_icon":0},{"id":"2562207277","title":"Incyte Corporation Files Initial Statement of Beneficial Ownership for Ramitpal K. Basi, EVP of Human Resources","url":"https://stock-news.laohu8.com/highlight/detail?id=2562207277","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562207277?lang=en_us&edition=fundamental","pubTime":"2025-08-28 04:43","pubTimestamp":1756327403,"startTime":"0","endTime":"0","summary":"Incyte Corporation filed an initial statement of beneficial ownership with the SEC, identifying Ramitpal K. Basi as the beneficial owner in the role of Executive Vice President, Human Resources. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incyte Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 27, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nNDL29XzLx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY","BK4588","BK4585","BK4139","BK4550","BK4532"],"gpt_icon":0},{"id":"2562204817","title":"BRIEF-Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2562204817","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562204817?lang=en_us&edition=fundamental","pubTime":"2025-08-28 04:36","pubTimestamp":1756326970,"startTime":"0","endTime":"0","summary":"BRIEF-Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)Aug 27 (Reuters) - Incyte Corp INCY.O:INCYTE REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)Source text: ID:nBw6kVnxDaFurther company coverage: INCY.O ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nTUA26KMGG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY","BK4550","BK4139","BK4588","BK4532","BK4585"],"gpt_icon":0},{"id":"2562271727","title":"Incyte Corporation Announces New Equity Inducement Awards for Executive VP Soni Basi Under 2024 Stock Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2562271727","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562271727?lang=en_us&edition=fundamental","pubTime":"2025-08-28 04:15","pubTimestamp":1756325716,"startTime":"0","endTime":"0","summary":"Incyte Corporation announced the induction of Soni Basi as the new Executive Vice President and Chief Human Resources Officer, accompanied by a comprehensive equity inducement package. Effective August 25, 2025, Ms. Basi will receive stock options to purchase 29,230 shares of Incyte's common stock at an exercise price of $84.76 per share. These options have a ten-year term, with 25% vesting after one year and the remainder vesting monthly over three years. Additionally, Ms. Basi is granted 6,506 restricted stock units, vesting over four years, and performance shares targeting 16,265 shares, contingent on the company's relative total shareholder return over a three-year period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incyte Corpo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nNDL77CfhN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","BK4585","BK4588","BK4139","BK4532","INCY"],"gpt_icon":0},{"id":"2562824030","title":"Actuate Therapeutics Announces New Phase 1b Trial of Elra in Combination with Retifanlimab and mFOLFIRINOX for Advanced Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2562824030","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562824030?lang=en_us&edition=fundamental","pubTime":"2025-08-25 22:01","pubTimestamp":1756130472,"startTime":"0","endTime":"0","summary":"Actuate Therapeutics Announces New Phase 1b Trial of Elra in Combination with Retifanlimab and mFOLFIRINOX for Advanced Pancreatic Cancer. Actuate Therapeutics Inc. has announced plans for a Phase 1b clinical trial to evaluate the combination of their drug elra with Incyte Corporation's PD-1 inhibitor retifanlimab and modified FOLFIRINOX  as frontline therapy for advanced pancreatic adenocarcinoma. This study will be conducted in collaboration with UPMC Hillman Cancer Center and Incyte. The trial aims to explore synergistic opportunities for patients who have not yet received systemic therapy and to assess ways to optimize elraglusib's potential through a complementary multi-agent approach. Results from this trial have not yet been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nNDL1s25yf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4139","ACTU","INCY","BK4588","BK4550","BK4585"],"gpt_icon":0},{"id":"2562419962","title":"BRIEF-Incyte Names Soni Basi As Executive Vice President And Chief Human Resources Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2562419962","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562419962?lang=en_us&edition=fundamental","pubTime":"2025-08-25 20:27","pubTimestamp":1756124855,"startTime":"0","endTime":"0","summary":"BRIEF-Incyte Names Soni Basi As Executive Vice President And Chief Human Resources OfficerAug 25 (Reuters) - Incyte Corp INCY.O:INCYTE ANNOUNCES THE APPOINTMENT OF SONI BASI AS EXECUTIVE VICE PRESIDEN","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nTUA1WCJT4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","BK4588","BK4532","INCY","BK4550"],"gpt_icon":0},{"id":"2562249602","title":"Incyte Corporation Appoints Soni Basi as New Executive Vice President and Chief Human Resources Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2562249602","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562249602?lang=en_us&edition=fundamental","pubTime":"2025-08-25 20:00","pubTimestamp":1756123250,"startTime":"0","endTime":"0","summary":"Incyte Corporation has announced the appointment of Soni Basi as the new Executive Vice President and Chief Human Resources Officer, effective August 25, 2025. Ms. Basi, with over 25 years of experience in global HR and business leadership, will be responsible for shaping the company's global human resources strategy. She succeeds Paula Swain, who retired from the position.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incyte Corporation published the original content used to generate this news brief via Business Wire  on August 25, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nNDLMCQzp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","INCY","BK4585","BK4532","BK4588","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":184,"code":"91000000","status":"200"}]}}